Glenmede Trust Company »

Halozyme Therapeutics shares owned by Glenmede Trust Company

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Glenmede Trust Company from 13F filings

Historical chart of Glenmede Trust Company investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Glenmede Trust Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Glenmede Trust Company

Quarter filed Position value Share count Share price at filing
2023-09-30 $13M 343k 38.20
2023-06-30 $13M 347k 38.19
2023-03-31 $13M 346k 38.19
2022-12-31 $20M 342k 56.90
2022-09-30 $13M 385k 34.48
2022-06-30 $19M 431k 44.00
2022-03-31 $19M 478k 39.88
2020-09-30 $6.0k 241 24.90
2020-06-30 $3.0k 149 20.13
2019-09-30 $3.0k 200 15.00
2019-06-30 $3.0k 200 15.00
2019-03-31 $3.0k 200 15.00
2018-12-31 $2.0k 200 10.00
2018-06-30 $9.2k 574 16.04
2018-03-31 $13k 635 20.00
2017-12-31 $13k 635 20.00
2016-09-30 $999 173 5.78
2016-06-30 $999 173 5.78
2016-03-31 $999 173 5.78
2014-06-30 $5.0k 543 9.21
2014-03-31 $9.0k 743 12.11
2013-12-31 $8.0k 543 14.73